Related Experiment Video
Updated: Jul 13, 2026

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
Investigating the Impact of Circulating MicroRNAs on Knee and Hip Osteoarthritis: Causal Links, Biological
Shanni Li1, Yihui Peng2, Yang Yu1
1Peking Union Medical College, Chinese Academy of Medical Science, Beijing 100010, China.
Abstract:
Osteoarthritis (OA), particularly in the knee and hip, poses a significant global health challenge due to limited therapeutic options. To elucidate the molecular mechanisms of OA and identify potential biomarkers and therapeutic targets, we utilized genome-wide association studies (GWAS) and cis-miRNA expression quantitative trait loci (cis-miR-eQTL) datasets to identify miRNAs associated with OA, revealing 16 that were linked to knee OA and 21 to hip OA. Among these, hsa-miR-1303 was significantly upregulated in both knee and hip OA (IVW: p = 6.8164×10-36 and 4.7919×10-2 respectively, OR > 1) and identified as a key factor in disease progression. Hsa-miR-1303 potentially regulates 30 genes involved in critical signaling pathways, such as the neurotrophin signaling pathway, and interacts with competing endogenous RNAs (ceRNAs) like circ_0041843 and LINC01338, thereby influencing key regulatory proteins such as SUMO2 and PARP1. Pharmacologically, hsa-miR-1303 targets nine druggable genes, including NRAS, H2AZ1, and RPS3, which have implications for drugs like cantharidin and diindolylmethane, potentially critical for developing novel OA treatments. Conversely, hsa-miR-125a-5p and hsa-miR-125b-5p, which are downregulated in both knee and hip OA, are associated with pathways such as HIF-1 and JAK-STAT, which modulate apoptotic signaling and transcriptional regulation. These miRNAs also interact with ceRNAs such as circ_0000254 and SPACA6P-AS, impacting proteins like STAT3, MCL1, and TRAF6. A drug interaction analysis identified 47 potential treatments, including Resveratrol and Acetaminophen, suggesting new therapeutic possibilities for OA management. This study not only highlights the role of miRNAs like hsa-miR-1303 and hsa-miR-125 in OA but also opens avenues for miRNA-based therapeutic development.
Insights
This study identifies key microRNAs (miRNAs) involved in osteoarthritis (OA) progression. Upregulated hsa-miR-1303 and downregulated hsa-miR-125 family miRNAs offer potential therapeutic targets for developing novel OA treatments.
Area of Science:
- Genetics and Molecular Biology
- Biomarkers and Therapeutics Development
- Osteoarthritis Pathogenesis
Background:
- Osteoarthritis (OA) is a global health challenge with limited treatment options, necessitating research into its molecular mechanisms.
- MicroRNAs (miRNAs) are emerging as critical regulators in various diseases, including OA, impacting gene expression and cellular pathways.
Purpose of the Study:
- To identify specific miRNAs associated with knee and hip osteoarthritis using genome-wide association studies (GWAS) and cis-miRNA expression quantitative trait loci (cis-miR-eQTL) data.
- To elucidate the regulatory roles of identified miRNAs in OA pathogenesis and explore their potential as therapeutic targets.
Main Methods:
- Utilized GWAS and cis-miR-eQTL datasets to identify miRNAs linked to knee and hip OA.
- Analyzed the regulatory networks of key miRNAs, including interactions with target genes and competing endogenous RNAs (ceRNAs).
- Performed drug interaction analysis to identify potential therapeutic agents targeting identified miRNA pathways.
Main Results:
- Identified 16 miRNAs for knee OA and 21 for hip OA; hsa-miR-1303 was significantly upregulated in both, implicating it in OA progression.
- Hsa-miR-1303 regulates genes in pathways like neurotrophin signaling and interacts with ceRNAs, affecting proteins SUMO2 and PARP1.
- Downregulated hsa-miR-125a-5p and hsa-miR-125b-5p are linked to HIF-1 and JAK-STAT pathways, impacting apoptosis and STAT3, MCL1, TRAF6 proteins; 47 potential OA treatments identified.
Conclusions:
- Hsa-miR-1303 and the hsa-miR-125 family play significant roles in the molecular mechanisms of knee and hip osteoarthritis.
- These miRNAs, along with their regulatory targets and ceRNAs, represent promising biomarkers and therapeutic targets for novel OA treatments.
- The study provides a foundation for developing miRNA-based therapeutic strategies to manage osteoarthritis effectively.
More Related Videos
07:10Micro-Computed Tomography Analysis of the Knee in Aged Dunkin-Hartley Guinea Pigs after Intra Articular Injection
Published on: August 2, 2024
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
MicroRNAs
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
The JAK-STAT Signaling Pathway